L84-33170-25475
5 vaccinations
2 coded responses
63 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 350 / AL
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
BZ6-20417-24120
Child or adolescent in my care · Male · 2021-11-07
H7N-21116-55994
Child or adolescent in my care · Male · 2021-11-07
3VJ-10641-58750
Child or adolescent in my care · Male · 2022-10-11
HBE-91682-65697
Child or adolescent in my care · Male · 2022-12-16
Timeline
-
2021-02-11
Registered in v-safe
-
2021-02-11
Dose 1 — Pfizer-BioNTech
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-25
-
2021-03-04
Dose 2 — Pfizer-BioNTech
- 2021-03-04
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-07
- 2021-03-08
- 2021-03-09
-
2021-03-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
-
2021-06-03
Survey response — 3 months, dose 2MedDRA: Gastrointestinal disorder, Nasopharyngitis — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Cold and stomach issuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-27
Dose 3 — Pfizer-BioNTech
-
2021-08-27
Survey response — day 0, dose 3MedDRA: Pregnancy — Feeling: FairFree text: Pregnant, already feeling sickMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-08-30
- 2021-08-31
- 2021-09-01
- 2021-09-02
- 2021-09-03
- 2021-09-10
- 2021-09-17
- 2021-09-24
- 2021-10-01
- 2021-10-08
- 2021-11-26
-
2022-02-04
Dose 4 — Moderna
- 2022-02-04
- 2022-02-05
- 2022-02-06
- 2022-02-07
- 2022-02-08
- 2022-02-09
- 2022-02-10
- 2022-02-11
- 2022-02-18
- 2022-02-25
- 2022-03-04
- 2022-03-11
- 2022-03-18
- 2022-05-06
- 2022-08-05
-
2022-09-08
Dose 5 — Pfizer-BioNTech
- 2022-09-08
-
2022-09-09
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-10
- 2022-09-11
- 2022-09-12
- 2022-09-17
- 2022-09-22
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-12-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-11 | Pfizer-BioNTech | |
| 2 | 2021-03-04 | Pfizer-BioNTech | |
| 3 | 2021-08-27 | Pfizer-BioNTech | No |
| 4 | 2022-02-04 | Moderna | No |
| 5 | 2022-09-08 | Pfizer-BioNTech | No |
Free text
Release 8 — 3 months, dose 2
Symptoms: Cold and stomach issues
Release 9 — day 0, dose 3
Systemic reaction (other): Pregnant, already feeling sick
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SRO | Pregnancy | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release